Medicine and Dentistry
Craniopharyngioma
100%
Alpha Defensin
66%
Interferon Alfa
50%
Innate Immunity
50%
Cyst
33%
Cyst Fluid
33%
Patient
33%
Surgery
16%
Pathogenesis
16%
Immunoglobulin
16%
Morbidity
16%
Drug Therapy
16%
Serositis
16%
Protein
16%
High-Performance Liquid Chromatography
16%
Peptide
16%
Blood Brain Barrier
16%
Childhood Cancer
16%
Epithelial Cell
16%
Disease Course
16%
Electrospray Mass Spectrometry
16%
Polypeptide Antibiotic Agent
16%
Analysis
16%
Therapeutic Procedure
16%
Cells
16%
Pathology
16%
Mechanism of Action
16%
Blood Vessel
16%
Pharmacology, Toxicology and Pharmaceutical Science
Craniopharyngioma
100%
Alpha Defensin
66%
Alpha Interferon
50%
Cyst
33%
Cyst Fluid
33%
Protein
16%
Pathogenesis
16%
Blood-Brain Barrier
16%
Peptide
16%
Immunoglobulin
16%
Morbidity
16%
Polypeptide Antibiotic Agent
16%
Childhood Cancer
16%
Disease Course
16%
Immunology and Microbiology
Liquid
83%
Innate Immune System
50%
Interferon Alfa
50%
Reduction (Chemistry)
33%
Mass Spectrometry
33%
Morbidity
16%
Intravenous Immunoglobulin
16%
Antimicrobial Peptides
16%
Electrospray Mass Spectrometry
16%
Blood Brain Barrier
16%
Alpha Defensin
16%
Cells
16%
Inflammation
16%
Molecule
16%
Childhood
16%
Biochemistry, Genetics and Molecular Biology
Liquid
83%
Defensin, Alpha 1
50%
Innate Immunity
50%
Reduction (Chemistry)
33%
Peptide
16%
Molecule
16%
High-Performance Liquid Chromatography
16%
Antimicrobial Peptides
16%
Glycopeptide Antibiotic
16%
Morbidity
16%
Blood Brain Barrier
16%
Electrospray Mass Spectrometry
16%
Alpha Defensin
16%
Childhood
16%
Neuroscience
Craniopharyngioma
100%
Interferon Alfa
50%
Intravenous Immunoglobulin
16%
Peptide
16%
Blood Brain Barrier
16%
Antimicrobial Peptides
16%
Alpha Defensin
16%
Squamous Epithelial Cell
16%
Protein
16%